Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review

Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review

PurposeTargeted radionuclide therapy (TRT) with [131I]MIBG and [177Lu]Lu-DOTA-TATE is an alternative treatment to the classic schemes in slow progressive metastatic/inoperable paraganglioma (PGL) and pheochromocytoma (PHEO). There is no consensus on which treatment to administer and/or the best sequ...

Full description

Bibliographic Details
Main Authors: Stefan Prado-Wohlwend, María Isabel del Olmo-García, Pilar Bello-Arques, Juan Francisco Merino-Torres
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Endocrinology
Subjects:
paraganglioma
131I-MIBG therapy
PRRT (peptide receptor radionuclide therapy)
theragnostic agents
pheochromocytoma
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.957172/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.957172/full

Similar Items